deferiprone has been researched along with kojic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basinger, MA; Jones, MM; Molenda, JJ | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Koster, JF; van der Kraaij, AM; van Eijk, HG | 1 |
| Behjati, M; Fassihi, A; Mohammadpour, M; Sadeghi, A | 1 |
4 other study(ies) available for deferiprone and kojic acid
| Article | Year |
|---|---|
Enhancement of iron excretion via monoanionic 3-hydroxypyrid-4-ones.
Topics: Alkanesulfonates; Animals; Anions; Bile; Chelating Agents; Crystallography, X-Ray; Female; Hydrogen-Ion Concentration; Iron; Molecular Structure; Pyridones; Rats; Rats, Sprague-Dawley | 1994 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol-3.
Topics: Animals; Antioxidants; Catechin; Chemical Phenomena; Chemistry; Coronary Circulation; Deferiprone; Iron Chelating Agents; L-Lactate Dehydrogenase; Lactates; Lactic Acid; Male; Myocardial Contraction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myocardium; Pyridones; Pyrones; Rats; Rats, Inbred Strains; Stereoisomerism | 1989 |
Wound healing by topical application of antioxidant iron chelators: kojic acid and deferiprone.
Topics: Administration, Topical; Animals; Antioxidants; Deferiprone; Disease Models, Animal; Drug Therapy, Combination; Female; Iron Chelating Agents; Mycotoxins; Pyridones; Pyrones; Rats; Rats, Wistar; Skin Ulcer; Treatment Outcome; Wound Healing | 2013 |